Physician

Paolo Pio Tempongko, MD

According to 2025 Medicare claims, Paolo Tempongko, MD (NPI: 1548781644) practices rheumatology in the Atlantic City-Hammonton, NJ market, with the plurality of this provider's patient population coming from Cape May, NJ. This provider's primary affiliated billing organization is SPECIALTY MEDCONSULTANTS LLC (NPI: 1831520931; TIN: 463579776) and primary practice location at 08210-2190.

Tempongko's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 682 traditional Medicare patients, billed 197,270 HCPCS/CPT codes, and received $3,629,272 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 2,315 prescription claims across 495 beneficiaries totaling $2,881,977 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 35 records totaling $1,114. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.8M$3.6M2022 Medicare payment: $9,165 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,087,647 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,629,272 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
202229180$9,165
202338770,108$1,087,647
2024682197,270$3,629,272

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.4M$2.9M2022 Drug cost: $6,713 (USD; Tot_Drug_Cst)2023 Drug cost: $454,600 (USD; Tot_Drug_Cst)2024 Drug cost: $2,881,977 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20221320$6,713
2023219676$454,600
20244952,315$2,881,977

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more214214$181
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more296435$150
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more434807$97
96401Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle197962$58
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's5621,066$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Enbrel SureclickEtanercept451,260$329,981
Humira(Cf) PenAdalimumab301,064$263,875
OrenciaAbatacept/Maltose521,456$259,608
Taltz AutoinjectorIxekizumab261,008$237,771
Simponi AriaGolimumab281,306$202,495

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.35$1,114Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Paolo Pio Tempongko, MD?

Tedicare shows public-source Medicare data for Paolo Pio Tempongko, MD (NPI 1548781644), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Paolo Pio Tempongko, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Paolo Pio Tempongko, MD?

Paolo Pio Tempongko, MD is linked to SPECIALTY MEDCONSULTANTS LLC (billing NPI 1831520931) in the available physician profile data.

Does Paolo Pio Tempongko, MD have Open Payments data?

Paolo Pio Tempongko, MD has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.